Yu Changjiang, Li Ying, Adilijang Abuduresuli, Yan Jizhong, Guzalnur Arkin, Abudushalamu Abudula, Aimirela Yimamu, Fan Ruixin
Guangdong Provincial People's Hospital//Guangdong Cardiovascular Institute//Guangdong Provincial Key Laboratory of South China Structural Heart Disease//Guangdong Academy of Medical Sciences, Guangzhou 510080, China.
Department of Cardiac Surgery, Guangdong Provincial People's Hospital Affiliated to South China University of Technology, Guangzhou 510100, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Nov 30;40(11):1607-1614. doi: 10.12122/j.issn.1673-4254.2020.11.11.
To explore genetic mutation types and their correlation with clinical phenotypes in Uighur patients with aortic disease in Kashgar (Xinjiang Uighur Autonomous Region, China).
We examined 37 pathogenic genes in 19 Uighur families with aortic diseases including Marfan syndrome from Kashgar using next generation sequencing, and the results were confirmed by Sanger sequence in the first relatives.
This study included 19 families with aortic diseases, in whom a total of 23 variants were identified, and 11 (57.89%) probands had one or more variants. Among them, definite pathogenic mutation was detected in one patient (5.26%), variants of uncertain significance (VUS) were found in 8 (42.11%), and benign/likely benign variants were detected in 7 (36.84%). The 23 variants identified included one (5.26%) pathogenic variant, 14 (60.87%) VUS, and 8 (34.78%) benign/likely benign variants. The 14 VUS were analyzed by prediction with SIFT and Polyphen2 HDIV, which identified 6 (42.86%) variants as deleterious/possibly damaging; all the 8 benign/likely benign variants were predicted to be deleterious/possibly damaging.
We detected 23 genetic variants in the 19 Uighur families with aortic diseases, and 22 of these variants remain to be verified by more patient data in future studies.
探讨中国新疆维吾尔自治区喀什地区维吾尔族主动脉疾病患者的基因突变类型及其与临床表型的相关性。
我们使用二代测序技术检测了喀什地区19个患有包括马凡综合征在内的主动脉疾病的维吾尔族家庭中的37个致病基因,并在一级亲属中通过桑格测序对结果进行了验证。
本研究纳入了19个患有主动脉疾病的家庭,共鉴定出23个变异,11名(57.89%)先证者有一个或多个变异。其中,1例患者(5.26%)检测到明确的致病突变,8例(42.11%)发现意义未明的变异(VUS),7例(36.84%)检测到良性/可能良性变异。鉴定出的23个变异包括1个(5.26%)致病变异、14个(60.87%)VUS和8个(34.78%)良性/可能良性变异。通过SIFT和Polyphen2 HDIV对14个VUS进行预测分析,其中6个(42.86%)变异被鉴定为有害/可能有害;所有8个良性/可能良性变异均被预测为有害/可能有害。
我们在19个患有主动脉疾病的维吾尔族家庭中检测到23个基因变异,其中22个变异有待未来更多患者数据进行验证。